tiprankstipranks
Belite Bio, Inc. ADR (BLTE)
NASDAQ:BLTE
US Market

Belite Bio, Inc. ADR (BLTE) Income Statement

Compare
27 Followers

Belite Bio, Inc. ADR Income Statement

Last quarter (Q2 2024), Belite Bio, Inc. ADR's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Belite Bio, Inc. ADR's net income was $-9.49M. See Belite Bio, Inc. ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -399.00K$ -198.00K$ -30.00K$ -17.00K
Operating Expenses
$ 31.67M$ 12.82M$ 9.80M$ 5.74M
Depreciation and Amortization
$ 139.00K$ 198.00K$ 30.00K$ 17.00K
EBITDA
$ -31.53M$ -12.43M$ -9.64M$ -5.71M
Operating Income
$ -31.67M$ -12.82M$ -9.80M$ -5.74M
Other Income/Expenses
$ 45.00K$ 173.00K$ 131.00K$ -9.00K
Pretax Income
$ -31.62M$ -12.65M$ -9.67M$ -5.75M
Net Income
$ -31.63M$ -12.47M$ -9.79M$ -5.75M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.19$ -0.62$ -0.41$ -0.24
Diluted EPS
$ -1.19$ -0.62$ -0.41$ -0.24
Weighted Average Shares Outstanding
26.59M 19.98M 24.10M 24.10M
Weighted Average Shares Outstanding (Diluted)
26.59M 19.98M 24.10M 24.10M
Currency in USD

Belite Bio, Inc. ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis